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Abstract
Background: Cytoplasmic polyadenylation element binding proteins (CPEBs) regulate translation
by binding to regulatory motifs of defined mRNA targets. This translational mechanism has been
shown to play a critical role in oocyte maturation, early development, and memory formation in
the hippocampus. Little is known about the presence or functions of CPEBs in the retina. The
purpose of the current study is to investigate the alternative splicing isoforms of a particular CPEB,
CPEB3, based on current databases, and to characterize the expression of CPEB3 in the retina.
Results: In this study, we have characterized CPEB3, whose putative role is to regulate the
translation of GluR2 mRNA. We identify the presence of multiple alternative splicing isoforms of
CPEB3 transcripts and proteins in the current databases. We report the presence of eight
alternative splicing patterns of CPEB3, including a novel one, in the mouse retina. All but one of the
patterns appear to be ubiquitous in 13 types of tissue examined. The relative abundance of the
patterns in the retina is demonstrated. Experimentally, we show that CPEB3 expression is
increased in a time-dependent manner during the course of postnatal development, and CPEB3 is
localized mostly in the inner retina, including retinal ganglion cells.
Conclusion: The level of CPEB3 was up-regulated in the retina during development. The presence
of multiple CPEB3 isoforms indicates remarkable complexity in the regulation and function of
CPEB3.
Background
Translational regulation plays a major role in temporal
and spatial gene expression in a wide variety of situations.
Modification of translation initiation factors lead to glo-
bal regulation that controls the translation of the tran-
scriptome as a whole. Modification of regulatory factors
specifically binding to mRNA motifs in the 3' or 5'
untranslated regions (UTRs) can modulate the translation
of defined groups of mRNAs [1]. Accumulated evidence
now indicates that mRNA-specific regulatory factors exist
as either multi-protein complexes, such as cytoplasmic
polyadenylation element binding proteins (CPEBs) [2], or
multi-proteins complexes containing a non-coding RNA
(siRNA or miRNAs) [3]. We now know that mRNA-spe-
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cific translational control is essential for many biological
processes including development, differentiation, and
nervous system plasticity. Reports on the existence of
these translational control mechanisms have added
another layer of complexity to our understanding of gene
regulation but this has been little explored in the retina.
Cytoplasmic polyadenylation was first brought to light in
the 1980s, for its role in boosting translation of quiescent
maternal mRNAs during oocyte maturation when little
transcription activity is present [4-6]. This emerging area
has particular significance for the nervous system because
it provides insight into the molecular underpinnings of
synaptic plasticity. The existence of a cytoplasmic polya-
denylation mediated control system became a subject of
interest to neuroscientists about a decade ago when it was
first investigated in the hippocampus and the visual cortex
[7]. In this case, CPEB1 was shown to control the polyade-
nylation and translation of Ca2+/calmodulin-dependent
protein kinases α (CaMKIIα) mRNA upon N-methyl-D-
aspartate receptor (NMDAR) activation. Four paralogous
CPEBs (CPEB1-4) have been characterized in mouse
[2,8,9]. One of these paralogs, CPEB3, is dendritically
localized in the hippocampus and was shown to be co-
immunoprecipitated with glutamate receptor subunit 2
(GluR2) mRNA. The knockdown of CPEB3 mRNA with
the aid of small interfering RNAs (siRNA) resulted in
enhanced translation of the synaptic protein GluR2 in
neurons of the hippocampus [10].
Activity-dependent synaptic plasticity refers to the ability
of neurons to change their synaptic strength and efficacy
in adaptation to input. It can be embodied in several
forms, including changes in the amount of neurotrans-
mitters released from presynaptic terminals [11,12], alter-
ation in the composition, density or activity of receptors/
ion channels on postsynaptic membrane [13], re-remode-
ling of synaptic structure [14], and an increase or decrease
in the number of synapses [15]. Synaptic plasticity has
long been recognized at higher levels of the central nerv-
ous system (CNS), such as the cerebral cortex [16], the
hippocampus [17], the cerebellum [18], and higher levels
of the visual system [19].
Recent studies of the neural retina indicate that it may
share some of these characteristics of activity-dependent
plasticity. For example, dark-rearing suppressed the matu-
rational pruning of dendrites in the inner plexiform layer
which normally occurs after eye-opening [20-22]. Visual
deprivation elevated the expression of several synaptic
related molecules in the retina [23,24]. Light responsive-
ness and oscillatory potentials were inhibited in both
young and adult dark-reared animals [25]. The composi-
tion of α-amino-3-hydroxy-5-methyl-4-isoxazole propi-
onate receptor (AMPAR) in the retinal ganglion cells
switches from predominantly GluR2-containing in the
light phase to GluR2-lacking in the dark phase [26,27].
The molecular mechanisms controlling such events in the
retina remain to be determined. A good candidate is
CPEB-regulated translational control. Evidence has sug-
gested the presence of CPEB1 in mouse retina [28], octpus
retina [29], and the expression of CPEB1-4 mRNAs in
embryonic Xenopus retina [30]. The current study dem-
onstrates the existence of multiple CPEB3 transcript vari-
ants in the retina. The presence of CPEB3 protein is also
shown in this tissue.
Results
Bioinformatics analysis of transcripts and protein isoforms 
of CPEB3
A previous study characterized four different alternative
splicing variants of CPEB3 transcripts [9], in which two
short motifs of 69 nucleotides (nt) and 24 nt (coding for
23 amino acids and 8 amino acids, respectively) are
removed individually, or concurrently. However, the
structure of CPEB3 seems to be more variable than previ-
ously reported. When investigating a nucleotide database
(UniGene) for CPEB3 variants, we were able to identify
eight transcripts labeled here as transcript variants 1a, 1b,
1c, 1d, 3, 4, 5 and 6 (figure 1). With the aid of sequence
alignment tools (UCSC Genome Browser Blat), we
mapped each cDNA to mouse genomic DNA, and
acquired the information related to alternative splicing. In
addition to the two previously reported short sequences
(69 nt and 24 nt) whose presence or absence results in 4
variants [9], several other alternative splicing regions were
discovered and elaborated here in diagrammatic form
(figure 1). A similar search for the protein databases (Uni-
Prot and NCBI) identified six distinct CPEB3 protein iso-
forms labeled here as isoforms 1 through 6 (figure 2).
With the bioinformatics tool Vector NTI, we inferred the
matches between cDNA variants and protein isoforms,
and designated the same numeric names to the matching
transcripts and protein isoforms (figure 1, 2). Transcript
1a, 1b, 1c and 1d all give rise to protein isoform 1.
In addition to the previous reported alternative splicing
regions [9], one of the alternative splicing locations iden-
tified in the current study was near exon 11. The prototyp-
ical transcripts have exon 12 immediately following exon
11 (figure 1, transcripts 1a-1d, 3, 4, and 6). However, tran-
script 5 has exon 11 extended, which causes a completely
different 3' UTR and the omission of exon 12 (figure 1).
As a result, the derived protein isoform 5 terminates with
four unique amino acids (GEWK) and is devoid of the sec-
ond RNA recognition motif (RRM) and the zinc finger
domain (figure 2).
Another variable region identified here was located within
exon 4. A 388 nt partial exon skipping within exon 4BMC Molecular Biology 2009, 10:109 http://www.biomedcentral.com/1471-2199/10/109
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causes the use of an alternative translation start codon
(figure 1, transcript 6), resulting in the removal of the first
216 amino acids in the derived protein (figure 2, isoform
6). Interestingly, this deletion removed the 197th serine,
which is a phosphorylation site of CPEB3 [31].
While the splicing patterns described above could result in
various protein isoforms, we found several other splicing
patterns which would not lead to altered protein
sequences but would rather lead to variance in their UTR
regulatory regions. For example, transcripts 1a, 1b, 1c use
different 5'UTRs (exons 1, 2, and 3 respectively). Tran-
script 1d uses a different 3' UTR (via the use of an alterna-
tive polyadenylation signal in exon 13). Such variability is
the result of differentially regulated transcriptional initia-
tion and/or termination; it most likely leads to variation
in the translational regulation of the specific transcripts.
These interesting findings indicate the existence of a pre-
viously unrecognized complex regulatory control system
for CPEB3 transcription and translation.
Known transcripts of CPEB3 Figure 1
Known transcripts of CPEB3. Upper Panel: Representation of genomic DNA sequence. Boxes represented exons, and hor-
izontal lines represented introns. Lower Panel: CPEB3 transcripts derived from alternative splicing. Ten transcripts were 
shown, with their accession numbers and types of tissue (if reported to the UniGene database) given to the right. The alterna-
tive splicings of exon 4, 5, 7 and 11 would generate different proteins products. The alternative splicings upstream of the start 
codon (exon 1-3) or downstream of the stop codon (exon 13) would give rise to different 5' and 3' UTRs, respectively. Dashed 
lines represented undetermined sequences. Partial sequence of transcript 2 (exon 5-7) was confirmed with the aid of PCR in a 
previous study [10], but its complete sequence was not documented in the UniGene database. Transcript 7 was a novel variant 
identified in the current study, of which the sequence upstream of exon 10 and downstream of exon 12 was not determined. 
Translational start codons and stop codons were annotated on top of the genomic DNA. Darkened boxed represented exons 
that could be alternatively spliced.
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Several variants including a novel variant of CPEB3 are 
identified experimentally in the retina. One of the variants 
is selectively expressed among different tissue-types
We next investigated the expression of CPEB3 mRNA
within the P60 mouse retina. Regular RT-PCR studies
demonstrated that CPEB3 is present in the retina (figure
3a). We further investigated which of the known CPEB3
transcripts identified through our bioinformatics analyses
are expressed in the retina. The primer sets for RT-PCR
were designed to span exon 5-7, around exon 11, and the
partial exon skipping site within exon 4 (figure 3d, table
1, table 2). Since one amplicon may correspond to more
than one transcript (figure 1, figure 3d), for our purposes,
we named each amplicon as an alternatively spliced "pat-
tern" with a descriptive name rather than a numeric name.
For example, the exon 5-7 region has four patterns
("+69+24", "-69+24", "+69-24", and "-69-24"), and the
exon 11 region has two patterns ("exon 11 extension", or
"exon 11 + exon 12"). The patterns within each splicing
region are exclusive of one another. Each pattern corre-
Known isoforms of CPEB3 proteins Figure 2
Known isoforms of CPEB3 proteins. Gray boxes represented possible functional motifs. Dash-lined boxed represented 
deletions. For simplicity, the names of the motifs were only labeled in isoform 1. Poly-Q (poly-glutamine) and SA (poly serine-
alanine) were two unique motifs of CPEB3 that were absent in the other three CPEBs. In the current study, each of the seven 
isoforms was named corresponding to the same numbered cDNA transcripts depicted in figure 1. Protein isoform 1 was the 
longest (716 aa) and may be derived from cDNA transcripts 1a-1d. One possible polymorphorism was located at the 372th 
amino acid of CPEB3 isoform 1: it was an N (asparagine) in [UniProtKB/Swiss-Prot: Q7TN99-Q7TN101] and [GenBank: 
AAQ20843] but a P (proline) in [GenBank: NP_938042, BAE27791, BAC41458]. Although the sequence of [GenBank: 
BAC41458] was reported as 722 aa, we presume it was 716 aa, since the first 6 amino acids QQAAQT preceding the 7th amino 
acid M (methionine) was likely to be falsely generated by the prediction software. Isoform 7 was derived from computational 
translation based on the novel transcript 7 identified in the current study. The upstream sequence of this isoform was yet to be 
determined; but the in-frame translation of the identified sequence would result in truncated RRM1 ending with four unique 
amino acids (LNWQ) and removal of RRM2. 197P represented the 197th serine, a phosphorylation site [31]. The positions of 
the gray-box and dash-lined-box motifs were indicated at the top and the bottom, respectively. The lengths, molecular sizes 
and accession numbers were indicated to the right.
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lated to one or multiple transcripts. The correspondence
between each pattern and potential CPEB3 transcripts
were listed in table 2.
Amplicons of the PCR reactions were separated on agarose
gel, and the identities of individual bands were confirmed
by sequencing. Our results from these RT-PCR studies
demonstrated the presence of "+69+24", "-69+24" (figure
3b, lane 2), "exon 11 extension" (figure 3b, lane3), the
"exon 11 + exon 12" (figure 3b, lane 4 upper band), and
"partial exon skipping within exon 4" splicing patterns in
the retina. Additionally, a novel CPEB3 splicing pattern,
"exon 11 deletion" (figure 3b, lane 4, lower band) was
identified in the retina. This was the first time this latter
pattern has been reported and was named here as "tran-
script 7" (figure 1).
In the exon 5-7 region, although only two bands were
detected with RT-PCR, it is possible that more dominant
transcripts "masked" weaker transcripts by competing for
the same primers. Therefore, we designed separate sets of
primers for each individual splicing pattern in this region
to further confirm their presence or absence (figure 3c).
Each specific band was purified and sequenced for confir-
mation. Our results demonstrated that the "+69-24" and
"-69-24" splicing patterns were indeed present in the ret-
ina (figure 3c). Multiple tissues were used to determine
the tissue specificity of the above splicing patterns. Of all
the patterns examined, the majority did not appear to dif-
fer with respect to tissue distribution. The only exception
was the "+69+24" pattern, which was expressed in the
central nervous system, ovary, testis, kidney and heart, but
Table 1: Primers used in RT-PCR.
Gene Primer name Primer sequence
β-actin fwd 5'-TGAAGATCAAGATCATTGCTCC-3'
rev 5'-TTAAAAAAACAAAGCCATGCC-3'
MAPK1 fwd 5'-GCATGGTTTGCTCTGCTTATGA-3'
MAPK1 rev 5'-ATTTTTATCTCTCTTAGGGTTCTTTGACAG-3'
CPEB3 fwd (f) 5'-CATCAAGGATAAACCGGTGC-3'
rev (r) 5'-GAAGAATGGGGCAAACTTCC-3'
#1 5'-TGTCAATGTCGTTGTGTTGAAGTTGC-3'
#3 5'-GACTCCCACACCACAAGGATACACA-3'
#4 5'-GAAGGCGTCTTCAAAGGGAAAGAGA-3'
#5 5'-TATGATAAGGACTGACCATGAGCCTCTG-3'
#7 5'-AGGAGCTATGGGCGGAGACGA-3'
#8 5'-GCTGAGTCCCCAATGCCTTAGC-3'
#13 5'-CCCGTTTGTCAATGTCGTTGTGTT-3'
#16 5'-AAGGATAAACCGTTGAACTGGCA-3'
#17 5'-CATGAGCCTCTGAAAGGTAAACACT-3'
#18 5'-AAGACCGACCTCGTCTCCGC-3'
#19 5'-CATGAGCCTCTGAAAGGACGC-3'
#20 5'-GAAGACCGACTGTTAAGTGCCATA-3'
#21 5'-TTCGAGCTGTTGAACTGGCA-3'
#34 5'-CCGTTTGTCAATGTCGTTGTGT-3'
#39 5'-TCTCAGCAGCAGCAGCGG-3'
#40 5'-GCTGGGGCTGGCGGA-3'
Table 2: The splicing patterns of CPEB3, the corresponding CPEB3 primer pairs, and the associated transcripts.
Amplicon Primer Pair Corresponding Transcripts
CPEB3 f-r
flanking 69 nt and 24 nt 4-5
Flanking exon 11 1-7
+69+24 17-18 transcripts 1a-1d
+69-24 17-20 transcript 2
-69+24 19-18 transcripts 3, 5, 6
-69-24 19-20 transcript 4
exon 11 extension 3-8 transcript 5
exon 11 + exon 12 21-13 transcripts 1a-1d, 3, 4, 6
exon 11 deletion 16-34 a novel transcript, transcript
partial exon skipping within exon 4 39-40 transcript 6BMC Molecular Biology 2009, 10:109 http://www.biomedcentral.com/1471-2199/10/109
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Figure 3 (see legend on next page)
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was absent in the thymus, spleen, lung and liver (figure
3c).
CPEB3 transcription is up-regulated during postnatal 
development of the retina
To investigate the expression of CPEB3 during develop-
ment, Taqman-based real-time PCR was used to evaluate
the relative abundance of CPEB3 mRNA in the retinas of
mice at seven different postnatal ages (figure 4). 18S RNA
was used for normalization. An amplicon of 79 nt span-
ning exon 4 and exon 5 of CPEB3 was amplified. This
amplicon was inclusive of all known CPEB3 transcripts,
therefore, represented the totality of the CPEB3 tran-
scripts. The similarity of the amplification efficiency of
CPEB3 and 18S primer sets were pre-validated by the
manufacturer and verified in our laboratory (data not
shown). The level of CPEB3 mRNA was significantly
increased throughout the postnatal development and
stayed high when the animals reached adulthood (figure
4).
Since CPEB3 has multiple transcript variants in the retina,
we investigated which of the particular CPEB3 transcripts
were up-regulated during the period of postnatal develop-
ment using SYBR Green-based realtime PCR. Mitogen-
activated protein kinase 1 (MAPK1) mRNA, the transcrip-
tion level of which showed little fluctuation during devel-
opment in the retina (data not shown), was used for
normalization. MAPK1 primers and CPEB3 primer sets
specific for each splicing pattern (table 1, table 2, figure
3d) were designed in-house to generate amplicons of
between 75 bp and 150 bp for robust amplification. Sim-
ilar amplification efficiencies (89%-94%) were reached
under optimized conditions for all primers sets, allowing
quantitative comparisons between CPEB3 and MAPK1,
and among different CPEB3 splicing patterns (figure 5).
The data on seven different age groups demonstrated that
all CPEB3 transcript patterns examined had similar trends
of postnatal-related increases (figure 5). This is consistent
with our previous findings (figure 4).
Comparisons of the relative abundance of transcript pat-
terns within each region (figure 5) demonstrated that
within exon 5-7 region, the "-69+24" pattern was the most
abundant, and the "+69-24" pattern was the least abun-
dant. Within the region surrounding exon 11, the proto-
typical "exon 11 + exon 12" was the most abundant, while
both "exon 11 extension" and "exon 11 deletion" were
much less abundant. Of the eight transcript patterns, the
three most abundant were "-69+24", "exon 11 + exon 12",
and "partial exon skipping within exon 4" across all ages.
CPEB3 protein is regulated during postnatal development 
of the retina
We investigated the relative abundance of CPEB3 protein
in the developing retina with the aid of western blots. Two
antibody-labeled bands with molecular weights of ~130
kD and ~75 kD respectively were identified in western
blots and were both diminished by pre-adsorption with
recombinant CPEB3 protein or by depletion of CPEB3 in
Hela cells (figure 6). The ~75 kD band could be isoform 3
or isoform 4 based on their predicted sizes. The intensity
of the ~75 kD band increased significantly during postna-
tal development of the retina, which was consistent with
the postnatal increases in the level of CPEB3 transcripts
(figure 4, 5). The ~130 kD band could be a dimer, a pre-
protein, or a prion form of CPEB3. Since the ~130 kD
band was not weakened in reducing and denaturing con-
ditions (by adding 1,4-dithioerythritol or beta-mercap-
toethanol and boiling), it seems less likely to be a dimer.
The possibility of it being a pre-protein needs further evi-
dence. The transcripts shown here do not indicate the
presence of a protein larger than ~78 kD, neither is there
any such protein evident in the UniProt database. How-
ever, a previous study indicated the presence of a ~100 kD
CPEB3 protein [10]. With the aid of a different gel/buffer
The expression of CPEB3 as demonstrated by RT-PCR Figure 3 (see previous page)
The expression of CPEB3 as demonstrated by RT-PCR. a) CPEB3 was present in the P60 retina. b) Multiple CPEB3 
transcripts were present in the retina. Different primer sets for various CPEB3 transcripts (table1, table 2) were used for PCR. 
Each visible band was purified and sequenced, which confirmed the presence of six splicing patterns: "+69+24" (lane2, upper 
band), "-69+24" (lane2, lower band), "exon 11 extension" (lane3), "exon 11 + exon 12" (lane 4, upper band); a new pattern: 
"exon 11 deletion" (lane 4, lower band), and "partial exon skipping within exon 4". But it did not rule out the presence of "+69-
24" and "-69-24", since the competition for the same set of primers by a dominant pattern ("-69+24") may mask the weakly 
expressed variants. c) Demonstration of "+69-24" and "-69-24" patterns and comparison of tissue distribution of all patterns. 
Primer sets specific for each individual splicing pattern were used for PCR on thirteen different tissues from adult mice. Each 
specific band was purified and sequenced for identity confirmation. The results demonstrated the presence of "+69-24" and "-
69-24" patterns in the retina (lane 2) in addition to the 6 patterns identified in figure b). It also demonstrated the ubiquity of the 
majority of the patterns, with the exception of "+69+24", which was expressed in the CNS, the ovary, testis, kidney and heart, 
but not in the lung, liver, thymus and spleen. d) The locations of these primers were mapped to CPEB3. The corresponding 
relationships between the numeric primers and the splicing variants in figure a), b) and c) were listed in table 2. Darkened 
boxed represented exons that could be alternatively spliced.BMC Molecular Biology 2009, 10:109 http://www.biomedcentral.com/1471-2199/10/109
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system and different protein standards, we have since
found that the larger band appeared to be around 97 kD.
Therefore, it seems likely that the 100 kD band in the prior
study and the 130 kD band in our study are of the same
identity. We can only speculate that any transcripts for
CPEB3 proteins larger than 78 kD are yet to be discovered.
The possibility of it being a prion form [32,33] also needs
further investigation.
Some of the transcripts identified in the current study did
not show distinct protein bands in western blots. This
may be attributed to the relative abundance of the tran-
CPEB3 mRNA during postnatal development Figure 4
CPEB3 mRNA during postnatal development. The relative fold change in the amount of CPEB3 mRNA was shown with 
the aid of real-time PCR. Seven postnatal ages flanking the eye-opening event were used for this study. For each sample, the 
level of CPEB3 mRNA was normalized to that of 18S RNA in the exact same sample. All experiments were repeated three 
times. All ages were calibrated relative to the postnatal age P1 and expressed as fold changes. Statistically significant differences 
were found by ANOVA between sets of two bracketed ages as indicated (p <= 0.05). For each age, the number of samples n 
>= 6. Error bars represented standard error of the mean (SEM). The asterisk indicated the approximate time of eye-opening. 
The results demonstrated that CPEB3 was significantly up-regulated in the retina from P1 to P12 (before eye-opening), and 
from P16 to P30 (after eye opening), and reached maximum in the adulthood (P60).
CPEB3 transcription is upregulated in the developing retina
Postnatal developmental ages
P1 P7 P12 P14 P16 P30 P60
R
e
l
a
t
i
v
e
 
f
o
l
d
 
o
f
 
C
P
E
B
3
 
m
R
N
A
0
5
10
15
20
25
p<0.05
 
 
 
(eye opening)BMC Molecular Biology 2009, 10:109 http://www.biomedcentral.com/1471-2199/10/109
Page 9 of 19
(page number not for citation purposes)
script (a result of transcriptional regulation), or the varia-
bility in the 5' UTRs and 3' UTRs of the transcripts
(leading to translational regulation). It is likely that not all
transcripts are translated with equal efficiency under the
current paradigm. Therefore, some protein isoforms may
be expressed at very limited amounts, which are below the
level of detection with the method used here. However,
such isoforms may be expressed more robustly under
other more appropriate, but unknown stimuli.
CPEB3 transcripts are expressed in the inner retina
With the aid of in situ hybridization and light microscopy
we identified which types of cells in the retina express
CPEB3 mRNA in the P60 mouse. To ensure specificity, the
in situ hybridization probes were designed in a region
where little homology was found between CPEB3 and the
other CPEBs. A sense probe complementary to the anti-
sense probe was used as a negative control. The results
(figure 7) demonstrated that CPEB3 was localized pre-
Relative abundance of different CPEB3 transcript patterns during development of the retina Figure 5
Relative abundance of different CPEB3 transcript patterns during development of the retina. The levels of each 
mRNA was normalized to the level of MAPK1 mRNA in the same sample. All the transcript variants demonstrated similar 
increasing trends during postnatal development. The relative abundance at any given age demonstrated that the "-69+24" pat-
tern was the most abundant in exon 5-7 region; the "ex 11 + ex 12" pattern was the most abundant in the region surrounding 
exon 11; and "partial exon skipping within exon 4" pattern was abundant. For age P14, n = 3; for all the other ages, n = 4. Error 
bars represented standard error of the mean (SEM). The amplification efficiencies for all the primer sets used in realtime PCR 
were listed in the table below the graph.
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dominantly in the retinal ganglion cell (RGC) layer, and
to a less extent, in the inner margin of the inner nuclear
layer (INL). It was not clear if CPEB3 mRNA was also
present in the plexiform layers due to the limited resolu-
tion of this technique.
CPEB3 protein is expressed in the retina
To confirm the expression pattern of CPEB3 mRNA and to
better define the cell types containing CPEB3 protein, flu-
orescence immunocytochemistry with an antibody to
CPEB3 was used. A pattern was observed which was simi-
lar to that seen for the localization by in situ hybridization.
CPEB3 protein was strongly expressed in cells located
within the RGC layer, and to a less extent, within cells of
the inner boundary of the INL (figure 8, 9). Both the inner
plexiform layer (IPL) and the outer plexiform layer (OPL)
also showed pronounced immunolabeling of CPEB3. To
define the type of cells which express CPEB3 we used dou-
ble immunolabeling with cell type-specific markers in
combination with CPEB3. The ganglion cell-specific
marker microtubule-associated protein 1a (Map1a)
[34,35], and the cholinergic amacrine cell marker choline
acetyl transferase (ChAT) [36-41], were used. Confocal
microscope images indicated that most of the anti-CPEB3
labeled cells in the RGC layer were retinal ganglion cells
(figure 8), and a few were displaced amacrine cells (figure
9).
Discussion
This study demonstrated for the first time that CPEB3
mRNA and protein were present in the mouse retina. Mul-
tiple CPEB3 transcripts were shown to be present in the
retina. The majority of the transcripts described here
appeared to have a wide tissue distribution. A novel tran-
script of CPEB3 ("exon 11 deletion") was discovered and
was present in multiple tissues including the retina. In
addition, the "+69+24" transcript pattern had various tis-
sue distribution and was expressed in CNS tissues. The
results also demonstrated for the first time that all CPEB3
transcripts were up-regulated in the mouse retina during
postnatal development and reached maximum in adult-
hood.
The expression of CPEB3 proteins in the retina Figure 6
The expression of CPEB3 proteins in the retina. a) The regulation of CPEB3 protein during the postnatal development 
of the retina. CPEB3 western blot on retinal samples from seven different postnatal ages showed that the 75 kD band protein 
was increased during the development. Another band at ~130 kD was also present in the retina. Both bands diminished when 
the antibody was pre-adsorbed with the recombinant CPEB3 protein (the last lane). GAPDH was used as a loading control. b) 
Both of the 75 kD and the 130 kD bands diminished when Hela cells were transfected with CPEB3 siRNA. Cells in the negative 
control were treated with a negative control siRNA. GAPDH was used as a loading control.
si C3      -
  CPEB3
  GAPDH
a                                                                                                                 bBMC Molecular Biology 2009, 10:109 http://www.biomedcentral.com/1471-2199/10/109
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In situ hybridization of CPEB3 on P60 mouse retina Figure 7
In situ hybridization of CPEB3 on P60 mouse retina. Sense probe complementary to the antisense probe was used for 
the negative control. The probes were designed in a region with no significant homology to any other CPEB to ensure specifi-
city. The expression of CPEB3 mRNA was located mostly in the RGC layer and to a lesser extent, the INL. Scale bar repre-
sented 50 μm. ONL: outer nuclear layer; OPL: outer plexiform layer; INL: inner nuclear layer; IPL: inner plexiform layer; RGC: 
retinal ganglion cell layer.BMC Molecular Biology 2009, 10:109 http://www.biomedcentral.com/1471-2199/10/109
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CPEB3 variants provide for a higher level of regulation 
complexity than has been hitherto recognized
The large number of variants in the coding region,
together with variances in the 5' and 3' UTRs of CPEB3
(figure 1) provides evidence for an unexpected level of
regulatory and functional complexity of CPEB3. First of
all, the differences in CPEB3 protein sequences (figure 2)
add to the complexity of its function which may involve
different temporal and spatial patterns. The alternatively
used sequences may generate discrete "tags" that serve as
hallmarks for localization of the protein, catalysis by dis-
crete kinases/phosphatases/endopeptidases, or interac-
tion with different protein partners. As a result, the
activation, inhibition or turnover of CPEB3 proteins may
also be affected. For instance, the 8-amino acids motif
(present in isoform 1, 3, 5, and 6, figure 2) presumably
harbors phosphorylation sites for CaMKII, protein kinase
A (PKA) and p70S6 kinases [9]. The functional signifi-
cance of the 23-amino acids motif (present in isoform 1
and 2, figure 2) and the 4-amino acids motif GEWK
(present only in isoform 5, figure 2) is unknown, but is of
interest for future studies. The RNA recognition motifs
(RRMs) of isoforms 5 and 7 of CPEB3 were altered, which
would likely to impact their substrate specificities, similar
to an effect previously proposed for CPEB1 [42].
Secondly, the regulatory properties of CPEB3 can stem
from the differences in the 5' UTR and 3' UTR regions of
the CPEB3 mRNAs. For example, transcripts 1a, 1b, 1c,
and 1d all yield the same protein product, but each has a
different 5' UTR or 3' UTR. The variability in the UTRs is
the result of differentially regulated transcription (alterna-
The presence of CPEB3 in P60 mouse retina Figure 8
The presence of CPEB3 in P60 mouse retina. We used double-immunofluorescence labeling with antibodies to CPEB3 
and Map1a. Map1a has been demonstrated as a marker for retinal ganglion cells. Most cells in the RGC layer were double-
labeled with CPEB3 and Map1a antibodies (arrows), suggesting that they are retinal ganglion cells. The INL was also labeled 
with CPEB3 antibody, with the innermost cells more intensely labeled. Both the IPL and the OPL were labeled with CPEB3 
antibody. The Map1a containing structures (arrowhead) in the OPL were non-specific since they also appeared in no primary 
control. The scale bar represented 50 μm.BMC Molecular Biology 2009, 10:109 http://www.biomedcentral.com/1471-2199/10/109
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The presence of CPEB3 in P60 mouse retina Figure 9
The presence of CPEB3 in P60 mouse retina. We used double-immunofluorescence labeling with antibodies to CPEB3 
and ChAT. ChAT is a marker for cholinergic amacrine cells. A few cells in the RGC layer were double-labeled with ChAT and 
CPEB3 antibodies, as indicated with the arrows. This suggested that a few CPEB3 positive cells in the RGC layer were dis-
placed amacrine cells. The size of such cells was usually smaller than those cells staining positive for both CPEB3 and Map1a. 
The INL was also labeled with CPEB3, with the innermost cells more intensely labeled. A few cells in the INL appeared to be 
double-immunopositive for ChAT and CPEB3 (arrowhead), suggesting that some CPEB3 positive cells in the INL were cholin-
ergic amacrine cells. Both the IPL and the OPL were labeled with CPEB3. Scale bar represented 50 μm.BMC Molecular Biology 2009, 10:109 http://www.biomedcentral.com/1471-2199/10/109
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tive transcriptional initiation and termination); such vari-
ability in the UTRs would further lead to discriminations
in translational regulation. The UTRs may also harbor sig-
nal motifs such as that for mRNA localization or degrada-
tion, hence subjecting the mRNA to distinct stimuli or
degradation pathways. The mechanisms for the transcrip-
tional and translational control of CPEB3 and the func-
tional significance of the UTR variants shown here
provide fertile ground for future investigations.
CPEB3 may play a role in synaptogenesis before eye 
opening
The level of CPEB3 was up-regulated during the postnatal
development and reached maximum abundance in adult-
hood (figure 4, 5). The presence of CPEB3 in the early ages
may be related to a possible role during synaptogenesis. It
is well established that the mammalian retina is prema-
ture at birth. The ganglion cell layer and the inner plexi-
form layer are recognizable at the time of birth, but the
remainder of the retina is yet to be fully developed. The
synaptogenesis in the IPL starts at day 3 [43,44]. Robust
glutamatergic synaptic formation occurs in the second
postnatal week, and synaptic sublamina becomes visible
in the IPL on day 12 [45]. The rate of synaptogenesis in the
IPL drops precipitously at day 15 (around the time of eye-
opening) [44]. Synaptic connections in the OPL begin to
develop on day 3 and are well established by day 12, when
the first light response was recorded as electroretinogram
(ERG) [46]. The synaptogenesis in both the IPL and the
OPL is concurrent with the increasing abundance of
CPEB3 seen during the early ages. Also noteworthy is the
pronounced labeling of CPEB3 proteins in the IPL and the
OPL (figure 8 and 9). This prompts the speculation that
CPEB3 expression is important for the process of synap-
togenesis; or alternatively, its expression is a consequence
of synapse formation.
Future studies on the interactions between CPEB3 protein
and mRNAs for synaptically relevant molecules, such as
AMPARs, NMDARs, CaMKII, and brain-derived neuro-
trophic factor (BDNF) mRNAs, can be employed to clarify
this issue. For example, AMPAR is involved in fast synaptic
transmission. GluR2/3 and 4 are expressed before the
emergence of synaptic transmission, indicating a role of
AMPAR in the establishment of retinal circuitry [47,48].
The onset and regulation of GluR2 expression in the retina
is in accordance with the process of synaptogenesis: it
starts early in postnatal development, and reaches a peak
before eye-opening [48,49]. The distribution pattern of
GluR2 in the IPL alters from a disoriented pattern just
after birth to a laminated pattern prior to eye-opening
[49], manifesting the reorganization of synaptic circuits.
The expression pattern of CPEB3 in the retina observed in
our study does appear to be consistent with that of GluR2.
Thus, both are expressed in the same types of cells, and
both are up-regulated in the first two weeks. Given the
previous notion that CPEB3 protein binds to GluR2
mRNA in hippocampal neurons and that GluR2 is a
potential target of CPEB3-mediated translational regula-
tion [10], it is plausible to conceive that CPEB3 also regu-
lates the translation of GluR2 during synaptogenesis in
the retina.
In addition to GluR2, there are several other synaptically-
relevant molecules that are localized in the RGCs and
amacrine cells and are developmentally up-regulated,
among which are AMPAR subunits GluR1, GluR4,
NMDAR subunits NR1, NR2A, NR2B, and CaMKIIα
[23,24,47,48]. A U-rich hairpin loop structure in the 3'
UTR of mRNAs has been identified as the binding motif
for CPEB4; such a motif was also recognized by CPEB3
[10]. Although other possible recognition motifs for
CPEB3 protein remain to be identified, the presence of the
U-rich hairpin structure in the 3' UTR of mRNAs could
serve as an indicator that these mRNAs may be targets of
CPEB3 regulated translational control. Potential CPEB3
targets containing the U-rich motif can be explored with
bioinformatics tools, and further verified with in vitro
binding assays [10] or in vivo manipulation of CPEB3
expression.
CPEB3 may play a role during synaptic maturation
Anatomical studies indicated that the retina matures at
postnatal day 41 [50]. Although most morphological and
neurochemical properties of the mouse retina (i.e. the
number of conventional and ribbon synapses, the expres-
sion of neurotransmitters receptors) have reached the
adult level at the time of eye opening [43,51], the matura-
tion of synaptic function continues for several weeks fol-
lowing eye-opening. The establishment of ON and OFF
pathways occurs to a large extent after eye opening. The
dendrites of RGCs ramifies widely in IPL during early
postnatal days [52], but remodels into a predominantly
monostratified form within sublamina a or sublamina b
of the IPL in two to three weeks after eye opening [22].
The synaptic strength of the RGCs, measured as the fre-
quency of spontaneous synaptic activity, is low around
the time of eye opening, but surges around P25 both in
spontaneous excitatory postsynaptic currents (sEPSCs)
mediated by glutamate receptors and in spontaneous
inhibitory postsynaptic currents (sIPSCs) mediated by
GABA/glycine receptors [53]. These maturational proc-
esses following eye-opening resonate with the continuing
increase of CPEB3 after eye opening. Whether such reso-
nance is coincidental or interrelated is an intriguing topic
for future studies.
CPEB3 and synaptic plasticity in the adulthood
Both our real-time PCR data and western blot data indi-
cated that CPEB3 continued to increase during develop-BMC Molecular Biology 2009, 10:109 http://www.biomedcentral.com/1471-2199/10/109
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ment and reached its highest level in adulthood. These
observations provide a strong indication that CPEB3 is
functional in adult retinas. Neuronal plasticity has been
historically characterized as a feature of the developing
CNS, but several lines of evidence indicate that some
forms of synaptic plasticity are not just the privilege of
developing animals.
One form of activity-driven synaptic plasticity in the adult
retina is described in the course of normal diurnal light/
dark cycles. GluR2-containing AMPARs undergo rapid
cycling in the RGCs and amacrine cells via endocytosis
and exocytosis [26]. Synaptic quiescence in the dark drives
rapid cycling resulting in the presence of AMPARs-lacking
GluR2 in the synaptic membrane. On the contrary, synap-
tic activity in the light period inhibits cycling and stabi-
lizes AMPAR as predominantly GluR2-containing
receptors on the cell surface. Such cycling of AMPARs is
also present in hippocampal neurons and plays a critical
role in synaptic plasticity in the adult hippocampus
[54,55]. Although the underlying mechanisms for AMPAR
cycling are yet to be fully deciphered, one may speculate
that CPEB3 plays a role in this process.
Conclusion
In conclusion, the current study demonstrated that CPEB3
is expressed in the retina. The levels of all transcripts were
up-regulated during postnatal development. We assume
that all of these transcripts have corresponding protein
products, but under the developmental paradigm used
here, not all protein products were detected. It is possible
that there are other paradigms which would lead to the
translation of the other transcripts. This needs to be fur-
ther explored. The variability in the protein-coding
regions and the UTRs indicates a remarkable degree of
complexity in both the regulation and function of CPEB3.
Methods
Bioinformatics
For CPEB3 transcript variants, the UniGene database [56]
and the UCSC Genome Browser database [57] was used.
For CPEB3 protein isoforms, the UCSC mouse proteome
database [58], the UniProt database [59] and the NCBI
protein database [60] were used. Sequence alignments
were carried out with the aid of Blast [61], UCSC Blat [62],
and Vector NTI (Invitrogen, Carlsbad, CA).
Animal handling and tissue preparation
All animal experimental procedures were performed in
compliance with University of Louisville IACUC animal
care regulations, as well as the ARVO statement for the use
of animals in ophthalmic and vision research. C57/BL6
mice were used for this study (Charles River Laboratories,
Davis, CA). Mice were euthanized with CO2 followed by
cervical dislocation. For RNA and protein extraction, the
eyes were removed and retina dissected immediately and
frozen on dry ice before proceeding to extraction. For in
situ hybridization and/or immunohistochemistry, whole
eyes were fixed in 4% paraformaldehyde for 12 hours at
4°C, then dehydrated in PBS buffer with 30% sucrose for
two weeks at 4°C. Snap-freezing embedding was carried
out in isopentane in a container placed on dry ice. The
temperature was kept below -70°C by adding crashed dry
ice into isopentane. The mounted tissue was then cut 14
microns thick on a cryostat on the same day or frozen air-
tight at -80°C for future sectioning.
RNA extraction
Frozen retina was homogenized rapidly using a PowerGen
250 homogenizer (Fisher Scientific, Pittsburgh, PA). Total
RNA was extracted using RNeasy mini kit (Qiagen, Valen-
cia, CA) following the manufacturer's instructions. The
concentration of RNA was determined using a BioPho-
tometer (Eppendorf, Westbury, NY), and the quality of
RNA decided by the ratio of 28S/18S on an agarose gel.
RNA was frozen in -80°C for long term storage.
RT-PCR
0.2 μg of total RNA was used for a 20 μl RT reaction using
AMV reverse transcriptase (Promega, Madison, WI). 1 μl
of the cDNA was used for PCR. The exon-exon junction
spanning, gene-specific primers for CPEB3, the control
gene β-actin, and specific CPEB3 transcripts were designed
in-house and obtained from IDT (Coralville, IA).
Sequences of these primers are listed in table 1. PCR was
carried out on a thermocycler using the following condi-
tions: 95°C 15 min for initial activation; 40 cycles of:
94°C 30 sec (denaturation), 60°C or 55°C 30 sec
(annealing), 72°C 30 sec (extension); lastly, 72°C 10 min
for extension. The resulting PCR products were visualized
on 1% agarose gels and photographed. Individual bands
were cut out, purified and sequenced to confirm their
identities.
Real-time PCR
0.2 μg of total RNA and the high capacity cDNA archive kit
(Applied Biosystems, Foster City, CA) was used for the
reverse transcription. The resulting cDNA was diluted 1:20
and 5 μl of the dilution was used for each PCR reaction.
For the overall expression of CPEB3 during development,
TaqMan Gene Expression Assay for CPEB3 (the mixture of
gene-specific primers and gene-specific, FAM-labeled
probes, ID# Mm01204293_m1, Applied Biosystems) and
TaqMan Gene Expression Assay for the endogenous con-
trol gene 18S (ID# Hs99999901_s1, Applied Biosystems)
were used. The CPEB3 primer-probe set generates a prod-
uct spanning exon 4-5, which represents all known CPEB3
transcripts. PCR master mix containing Taq DNA
polymerase, dNTPs and optimized reaction buffer were
also obtained from Applied Biosystems. PCR reactionsBMC Molecular Biology 2009, 10:109 http://www.biomedcentral.com/1471-2199/10/109
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were performed with an ABI 7300 real-time PCR system
using the following conditions: 50°C, 2 min; 95°C, 10
min; 40 cycles of (95°C, 15 sec; 60°C, 1 min). Data were
analyzed with the aid of SDS2.1 software (Applied Biosys-
tems). The RNA quantity for each sample was normalized
to 18S in the same sample and then calibrated to P1. This
provided an estimate of relative fold change compared to
P1.
For the quantification of individual CPEB3 transcript var-
iants, SYBR Green-based real-time PCR was used. MAPK1
was used for normalization. Transcript-specific, exon-
spanning primer sets were designed in house (table 1)
using Vector NTI; PCR master mix containing the DNA
polymerase, dNTPs, optimized buffer, and SYBR Green
was obtained from Applied Biosystems. PCR reactions
were performed with an ABI 7300 real-time PCR system
under the following conditions: 95°C, 10 min; 40 cycles
of (95°C, 15 sec; 60°C, 1 min); 95°C, 15 sec; 60°C, 30
sec; 95°C, 15 sec. Inclusion of the dissociation step would
reveal nonspecific products and primer dimmer or
duplexes, if any. When the specificity was validated, the
following optimization steps were performed for each set
of primers: the amount of forward/reverse primers (rang-
ing from 50 nM/50 nM to 900 nM/900 nM); the amount
of cDNA (varying the dilution factors); the annealing tem-
perature. Serial dilutions of a standard cDNA were used to
generate standard curves, based which the amplification
efficiencies were derived. Similarity within 5% difference
was considered acceptable for quantitative comparisons.
The primers were then used in quantitative analysis of
developmental samples. The relative quantity of RNA for
CPEB3 was normalized to that of MAPK1 in the same
sample. Data were analyzed with the aid of SDS2.1 soft-
ware.
In situ hybridization
14 um frozen sections were used for in situ hybridization.
Primers used in PCR amplification to generate the tem-
plate for probes (IDT, Coralville, IA) are listed in table 3.
PCR products were visualized on agarose gel and the spe-
cific band was cut out and purified using QIAquick Gel
Extraction Kit (Qiagen, Valencia, CA). The identity of the
purified product was confirmed by sequencing analysis,
which was later used as template for in vitro transcription
to generate DIG-labeled RNA probes (Invitrogen,
Carlsbad, CA). RNA probes were denatured at 85°C for 5
minutes then chilled on ice. Slides were treated with 0.1
M Rnase-free triethanolamine (TEA)-HCl pH 8.0 for 5
min, washed, and pre-hybridized at room temperature for
an hour in hybridization buffer, which was then replaced
with hybridization solution containing 100-200 ng/ml of
RNA probes for overnight incubation at 65°C. On the sec-
ond day, slides were washed in 0.2 × SSC several times
then transferred to buffer B1 (0.1 M Tris, 0.5 M NaCl,
pH7.5) for 5 minutes. Slides were then incubated in
buffer B2 (buffer B1 with 10% heat-inactivated sheep
serum) for 1 hour at room temp, after which buffer B2 was
replaced with buffer B2 containing anti-DIG antibody
(1:5000) for overnight incubation. On the third day,
slides were washed, equilibrated in buffer B3 (0.1 M Tris,
0.1 M NaCl, 50 mM MgCl2, pH9.5), and colorization
reaction was carried out in buffer B4 (buffer B3 with 20 μl/
ml NBT/BCIP stock solution and 0.1% tween-20). Slides
were then mounted in Mowiol mounting medium and
the results were analyzed with the aid of a microscope.
Protein extraction
Frozen retina was homogenized with the aid of a sonica-
tor (Biologics, Inc., Manassas, VA) in CelLytic MT cell lysis
buffer (Sigma, St. Louis, MO) with 1% (v/v) protease
inhibitor cocktail (Sigma). Samples were centrifuged at
1000 × g at 4°C for 10 minutes to remove tissue debris.
Protein concentration in the supernatants was determined
with the aid of the Bradford assay (Sigma, St. Louis, MO).
The samples were then dispensed into aliquots and stored
in -80°C.
Western blots
25 μg of total protein from each sample was loaded for
each lane in polyacrylamide electrophoresis (PAGE) and
gels were subsequently transferred to polyvinylidene fluo-
ride (PVDF) membrane. GAPDH was used as a loading
control. Antibodies were used at the indicated dilutions to
label the western blots (table 4). Protein standards cover-
ing the range of 10 kD to 250 kD (Bio-Rad, Hercules, CA)
were used as markers to determine the relative molecular
weights of antibody labeled protein bands in western
blots. Enhanced chemiluminescence reagent plus (ECL
plus, Thermo Fisher Scientific, Rockford, IL) was used to
detect the signal in the western blots. For negative controls
Table 3: Primers used to amplify probes for in situ hybridization.
Probe Forward primer Reverse primer
CPEB3-antisense 5'ACAGAGCCAGCTGCGCAAACCA3' 5'GTAATACGACTCACTATAGGG 
GAAGGTGCCTCCGAAGACCG3'
CPEB3-sense 5'GTAATACGACTCACTATAGGG 
ACAGAGCCAGCTGCGCAAACCA3'
5'GAAGGTGCCTCCGAAGACCG3'
The sequence in bold is T7 promoter.BMC Molecular Biology 2009, 10:109 http://www.biomedcentral.com/1471-2199/10/109
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we used recombinant CPEB3 protein to pre-absorb the
CPEB3 antibody.
To examine antibody specificity we used a recombinant
CPEB3 protein to pre-adsorb the antibody. This served as
a negative control. The recombinant protein was sepa-
rated with electrophoresis and subjected to mass spec-
trometry (MS) for identity confirmation. The fusion
protein was then purified and used as a blocking reagent
for the CPEB3 antibody.
Recombinant proteins
Full-length CPEB3 cDNA was cloned into pGEX2T vector
with a glutathionine S-transferase (GST) tag at the 5' end
(Keyclone, Cincinnati, OH). The protein was induced in
E. coli B21 cells by adding 0.8 mM isopropyl β-D-1-thi-
ogalactopyranoside (IPTG). Inclusion bodies were puri-
fied, solubilized with Inclusion Body Solubilization
Reagent (Thermo Fisher Scientific, Rockford, IL), and dia-
lyzed to physiological condition in a progressively
reduced concentration of urea in Tris·HCl (Thermo Fisher
Scientific). The recombinant protein was used for pre-
adsorption of antibody for western immunoblots to dem-
onstrate specificity of the antibody.
Immunohistochemistry
14 μm frozen sections were used for immunohistochem-
istry. All steps were carried out at room temperature. Sec-
tions were treated with TBS (pH7.4) containing 0.05%
Triton X-100 for 10 minutes before being blocked with
10% normal donkey serum in TBS for 1 hour. Sections
were then incubated with the primary antibodies at the
indicated concentration for 1 hour. After several washes,
secondary antibodies were applied for 1 hour. Slides were
washed again before being cover-slipped with Vectashield
mounting medium (Vector Laboratories, Burlingame,
CA). Immunolabeled sections were photographed with
the aid of a confocal microscope (Olympus, La Jolla, CA)
using 40× objective. A stack of 1 μm scans was combined
to produce the final images. The antibodies used in this
study, their source and dilutions are listed in table 5.
siRNA knockdown of CPEB3
Hela cells at confluence of 50-70% were transfected with
100 nM siRNAs duplexes using siPORT NeoFX reagent
(Applied Biosystems, Foster City, CA) in serum-contain-
ing medium. Cells were incubated with siRNA-containing
medium for 48 hours before being harvested. Proteins
were extracted using CelLytic M Mammalian Cell Lysis/
Extraction Reagent (Sigma, St. Louis, MO) with 100× pro-
tease inhibitors (Thermo Fisher Scientific, Rockford, IL)
Table 4: Antibodies, sources, and working concentrations used in western blots.
Antibodies Catalog and Company Species Working Concentration
CPEB3, polyclonal Ab10883
Abcam, Cambridge, MA
Rabbit 1:1000
GAPDH, monoclonal Img-5019A
Imgenex, San diego, CA
Mouse 1:5000
HRP conjugated secondary antibody, goat anti rabbit AP187P
Millipore, Bedford, MA
Goat 1:30,000
HRP conjugated secondary antibody, goat anti mouse AP130P
Millipore, Bedford, MA
Goat 1:30,000
Table 5: Antibodies, sources, and working concentrations used in immunohistochemistry.
Antibodies Catalog and Source Species Working Concentration
CPEB3, polyclonal Ab10883
Abcam, Cambridge, MA
Rabbit 1:50
Map1a, monoclonal M4278
Sigma,, St. Louis, MO
Mouse 1:200
ChAT, polyclonal AP144-p
Millipore, Bedford, MA
Goat 1:200
Alexa Fluor® 488 donkey anti-rabbit IgG (H+L) A11034
Invitrogen, Carlsbad, CA
Donkey 1:200
Alexa Fluor® 594 donkey anti-mouse IgG A21203
Invitrogen, Carlsbad, CA
Donkey 1:200
Alexa Fluor® 594 donkey anti-rabbit IgG (H+L) A21207
Invitrogen, Carlsbad, CA
Donkey 1:200
Alexa Fluor® 488 donkey anti-goat IgG A11055
Invitrogen, Carlsbad, CA
Donkey 1:200BMC Molecular Biology 2009, 10:109 http://www.biomedcentral.com/1471-2199/10/109
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and used for western blots. The sequences of CPEB3
siRNA duplexes were as following: sense strand:
CGAGUGGAACGCUACUCUAtt, antisense strand:
UAGAGUAGCGUUCCACUCGtt. Silencer® Negative Con-
trol #1 siRNA (Part Number AM4635, Applied Biosys-
tems, Foster City, CA) was used as a negative control.
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